Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study on the Preference of Risperidone Dosage Forms

NCT06657430 is registered in ClinicalTrials.gov with Shanghai Mental Health Center as lead sponsor.

NCT NCT06657430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06657430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study on the Preference of Risperidone Dosage Forms
Lead sponsor
Shanghai Mental Health Center
Phase
Observational
Overall status
Recruiting
Start date
September 19, 2024
Completion date
February 28, 2025
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder, bipolar affective disorder, conduct disorder, mental retardation, schizophrenia